BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Return on equity 2021–2025
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-89.5%FY2025 · since FY2021: -20.2% → -89.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -89.5% | -42.5 pp |
| FY2024 | -47.0% | -7.7 pp |
| FY2023 | -39.3% | -41.5 pp |
| FY2022 | 2.2% | +22.4 pp |
| FY2021 | -20.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice